Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Farage slams British prime minister for ‘extraordinary’ lack...
GOP senators say Trump’s strikes ‘significantly degraded’ Iran...
Trump tells Starmer aircraft carriers no longer needed...
King Charles to address ‘increasing pressures of conflict’...
‘Loud bang,’ damage reported at US Embassy in...
Iran’s last line of resistance holds back —...
State Department defends ‘proactive’ evacuation efforts against Dems’...
Cartels fear US retaliation as Trump-era pressure reshapes...
Trump vows block on signing new laws until...
Trump warns Iran’s new leader won’t ‘last long’...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

Pro-life group urges Senate to press RFK Jr. on abortion pill safety, demand safeguards return

by admin September 4, 2025
September 4, 2025
Pro-life group urges Senate to press RFK Jr. on abortion pill safety, demand safeguards return

The Restoration of America Foundation (ROAF) is calling on the Senate Finance Committee to hold Health and Human Services Secretary Robert F. Kennedy Jr. accountable at Thursday’s 10 a.m. hearing, demanding answers about the removal of safety protocols for the abortion pill mifepristone.

In a letter provided exclusively to Fox News Digital, ROAF argues the rollback leaves women more vulnerable and shifts costs to taxpayers.

ROAF argues that the Biden-era rollback of Risk Evaluation and Mitigation Strategy (REMS) requirements, safeguards in place for more than two decades, endangers women by allowing abortion pills to be prescribed via telehealth and delivered through the mail.

‘The removal of key Risk Evaluation and Mitigation Strategy (REMS) requirements for mifepristone has eliminated essential safeguards that protected women’s health for over two decades,’ said Doug Truax, founder and CEO of the Restoration of America Foundation. ‘We urge the Senate to demand clear answers about why these safety protocols were removed and when they will be reinstated.’

The Food and Drug Administration originally required mifepristone to be dispensed in person to ensure women were screened for potential complications such as ectopic pregnancy. That changed under the Biden administration, when telehealth prescribing and mail-order delivery were permitted for the first time.

Truax warned that ‘allowing these powerful drugs to be ordered online and sent through the mail without proper medical screening puts women at serious risk.’ He added, ‘Women deserve to know about potential complications and have immediate access to emergency care if needed.’

This post appeared first on FOX NEWS

previous post
US bolsters military presence in Caribbean near Venezuela amid Trump’s efforts to halt drug trafficking
next post
Trump’s political advisors huddle with House GOP over rebranding of the big beautiful bill

You may also like

Musk confident DOGE will save $1 trillion as...

May 31, 2025

Newsom rails against Trump’s 25% tariff plan during...

December 6, 2024

Experts sound alarm on Biden’s offshore drilling ban...

January 15, 2025

Walz says Harris picked him for VP to...

April 30, 2025

Sen. Joe Manchin calls on Biden to step...

July 21, 2024

Johnson reveals Trump’s wishes on delivering huge policy...

January 5, 2025

Harris tells NABJ she expects to ‘earn’ the...

September 18, 2024

Trump says US not willing to make deal...

April 7, 2025

KJP denies that Kamala Harris has had trouble...

October 22, 2024

White House calls Yemen ceasefire a ‘WIN’ –...

May 7, 2025

Recent Posts

  • Farage slams British prime minister for ‘extraordinary’ lack of support for Trump’s Iran strikes
  • GOP senators say Trump’s strikes ‘significantly degraded’ Iran but emphasize attacks not ‘forever wars’
  • Trump tells Starmer aircraft carriers no longer needed in Mideast, accuses him of joining war US ‘already won’
  • King Charles to address ‘increasing pressures of conflict’ in speech as Trump criticizes British PM on Iran
  • ‘Loud bang,’ damage reported at US Embassy in Norway; police investigating

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (981)
    • Investing (4,282)
    • Politics (5,172)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.